Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

Michael Rybak, PhaRM.D., M.P.h. is Professor of Pharmacy and Medicine, and Director, Anti-Infective Research Laboratory, Eugene Applebaum College of Pharmacy and Health Science, Wayne State University (WSU), Detroit, MI. ben loMaestRo, PhaRM.D., is Senior Clinical Pharmacy Specialist in Infectious Diseases, Albany Medical Center, Albany, NY. John c. RotschafeR, PhaRM.D., is Professor, Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis. RobeRt MoelleRing JR., M.D., is Shields Warren-Mallinckrodt Professor of Medical Research, Harvard Medical School, and Physician, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA. WilliaM cRaig, M.D., is Professor Emeritus, University of Wisconsin School of Medicine and Public Health, School of Medicine and Public Health, University of Wisconsin, Madison. MaRianne billeteR, PhaRM.D., bcPs, is Manager of Clinical Pharmacy Services at Ochsner Medical Center, New Orleans, LA. JosePh R. Dalovisio, M.D., Chairman, Department of Infectious Diseases, Ochsner Health System, New Orleans. DonalD P. levine, M.D., is Professor of Medicine and Chief, Division of General Internal Medicine, WSU. The following individuals are acknowledged for reviewing draft versions of this statement: Diane M. Cappelletty, Pharm.D.; Douglas N. Fish, Pharm.D., FCCP, FCCM, BCPS; William L. Greene, B.S., Pharm.D., BCPS, FASHP; David J. Ritchie, Pharm.D., FCCP, BCPS; Annette M. Rowden, Pharm.D., BCPS; Lynda J. Thompson, Pharm.D.; and Michael A. Wynd, Pharm.D., BCPS. Developed through the ASHP Council on Therapeutics and approved by the ASHP Board of Directors on June 26, 2008, the Infectious Diseases Society of America’s Board of Directors on June 16, 2008, and the Society of Infectious Diseases Pharmacists’ Board of Directors on June 25, 2008. Address correspondence to Ms. Cindy Reilly at the American Society of Health-System Pharmacists, 7272 Wisconsin Avenue, Bethesda, MD 20814 ([email protected]). The authors have declared no potential conflicts of interest.